OVERVIEW
The treatment landscape for inflammatory bowel disease (IBD) is evolving rapidly. Novel pharmacologic agents with different mechanisms of action are advancing the management of both ulcerative colitis and Crohn’s disease. Clinicians need education to stay abreast of the latest developments in IBD treatment, including positioning of new agents in treatment plans, efficacy and safety data, setting treatment goals, monitoring response, and adjusting treatment in patients who relapse. Join us for a fun, educational, and interactive "Jeopardy"-style symposium on IBD. Compete against your peers as you answer challenging questions on IBD management led by a professional host. Learn from expert faculty who will discuss the latest clinical evidence and nuances in clinical care in IBD that you can apply in your practices to improve patient outcomes.
Enhance Your Virtual Experience With Backstage Pass!
Join our 30-minute post-symposium breakout session connecting the program speakers and audience in the virtual environment. Backstage Pass provides an intimate virtual session where you can interact with faculty, address case-based questions, and facilitate relationship building.
*Video Encouraged*
GOAL STATEMENT
The goal of this activity is for learners to be better able to incorporate advanced targeted IBD therapies into clinical practice.
LEARNING OBJECTIVES
Upon completion of this activity, participants will: Have increased knowledge regarding the[LIST][ITEM]Mechanisms of action of new and emerging advanced/targeted treatments for IBD[/LIST]Have greater competence related to[LIST][ITEM] Implementing appropriate laboratory monitoring with the use of advanced IBD therapies[ITEM]Using patient-reported outcomes for assessing treatment response[/LIST]Demonstrate greater confidence in their ability to[LIST][ITEM]Select evidence-based, advanced IBD therapies based on patient-related factors such as comorbidities, age, and prior treatments[/LIST]
ACCREDITATION STATEMENT
In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. [JALOGO] [MEDSCAPE]
[bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 1.5 [italic][bold]AMA PRA Category 1 Credit(s)™[/bold][/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]For Nurses[/bold] Awarded 1.50 contact hour(s) of nursing continuing professional development for RNs and APNs.
Capital Hilton
Federal AB
1001 16th Street NW
Washington, District of Columbia, 20036
THIS PROGRAM IS NOT AFFILIATED WITH DIGESTIVE DISEASE WEEK®
Supported by an independent educational grant from [bold]AbbVie Inc[/bold].